Zhejiang Jolly Pharmaceutical Co.,LTD reported earnings results for the half year ended June 30, 2022. For the half year, the company reported sales was CNY 872.88 million compared to CNY 692.74 million a year ago. Revenue was CNY 894.95 million compared to CNY 697.67 million a year ago.

Net income was CNY 134.89 million compared to CNY 86.56 million a year ago. Basic earnings per share from continuing operations was CNY 0.2216 compared to CNY 0.1422 a year ago. Diluted earnings per share from continuing operations was CNY 0.2216 compared to CNY 0.1422 a year ago.